514 related articles for article (PubMed ID: 1567791)
1. Protection from experimental allergic encephalomyelitis by application of a bacterial superantigen.
Rott O; Wekerle H; Fleischer B
Int Immunol; 1992 Mar; 4(3):347-53. PubMed ID: 1567791
[TBL] [Abstract][Full Text] [Related]
2. Accelerated induction of experimental allergic encephalomyelitis in PL/J mice by a non-V beta 8-specific superantigen.
Soos JM; Hobeika AC; Butfiloski EJ; Schiffenbauer J; Johnson HM
Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6082-6. PubMed ID: 7541140
[TBL] [Abstract][Full Text] [Related]
3. Superantigens induce primary T cell responses to soluble autoantigens by a non-V beta-specific mechanism of bystander activation.
Rott O; Mignon-Godefroy K; Fleischer B; Charreire J; Cash E
Cell Immunol; 1995 Apr; 161(2):158-65. PubMed ID: 7535195
[TBL] [Abstract][Full Text] [Related]
4. Superantigen modulation of experimental allergic encephalomyelitis: activation of anergy determines outcome.
Racke MK; Quigley L; Cannella B; Raine CS; McFarlin DE; Scott DE
J Immunol; 1994 Feb; 152(4):2051-9. PubMed ID: 8120406
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to a TCR idiotope modulate the superantigen-induced responses of encephalitogenic rat T cells.
Zhou SR; DeSilva TS; Han Q; Whitaker JN
Int Immunol; 1994 Dec; 6(12):1865-74. PubMed ID: 7696205
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulation of experimental autoimmune encephalomyelitis by staphylococcal enterotoxin D.
Matsumoto Y; Fujiwara M
Cell Immunol; 1993 Jul; 149(2):268-78. PubMed ID: 7687198
[TBL] [Abstract][Full Text] [Related]
7. Treatment of PL/J mice with the superantigen, staphylococcal enterotoxin B, prevents development of experimental allergic encephalomyelitis.
Soos JM; Schiffenbauer J; Johnson HM
J Neuroimmunol; 1993 Mar; 43(1-2):39-43. PubMed ID: 8096223
[TBL] [Abstract][Full Text] [Related]
8. Pertussis toxin prevents the induction of peripheral T cell anergy and enhances the T cell response to an encephalitogenic peptide of myelin basic protein.
Kamradt T; Soloway PD; Perkins DL; Gefter ML
J Immunol; 1991 Nov; 147(10):3296-302. PubMed ID: 1719074
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo.
Khoury SJ; Gallon L; Chen W; Betres K; Russell ME; Hancock WW; Carpenter CB; Sayegh MH; Weiner HL
J Exp Med; 1995 Aug; 182(2):357-66. PubMed ID: 7543136
[TBL] [Abstract][Full Text] [Related]
10. Protection from experimental autoimmune encephalomyelitis (EAE): non-depleting anti-CD4 mAb treatment induces peripheral T-cell tolerance to MBP in PL/J mice.
Biasi G; Facchinetti A; Monastra G; Mezzalira S; Sivieri S; Tavolato B; Gallo P
J Neuroimmunol; 1997 Mar; 73(1-2):117-23. PubMed ID: 9058767
[TBL] [Abstract][Full Text] [Related]
11. T-cell vaccination prevents EAE effector cell development but does not inhibit priming of MBP responsive cells.
Bouwer HG; Hinrichs DJ
J Neurosci Res; 1996 Aug; 45(4):455-62. PubMed ID: 8872906
[TBL] [Abstract][Full Text] [Related]
12. Effects of staphylococcal enterotoxin B on T cell receptor V beta utilization and clinical manifestations of experimental allergic encephalomyelitis.
Kalman B; Lublin FD; Lattime E; Joseph J; Knobler RL
J Neuroimmunol; 1993 Jun; 45(1-2):83-8. PubMed ID: 7687252
[TBL] [Abstract][Full Text] [Related]
13. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
Jung S; Toyka K; Hartung HP
Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
[TBL] [Abstract][Full Text] [Related]
14. Intramolecular epitope spreading induced by staphylococcal enterotoxin superantigen reactivation of experimental allergic encephalomyelitis.
Soos JM; Mujtaba MG; Schiffenbauer J; Torres BA; Johnson HM
J Neuroimmunol; 2002 Feb; 123(1-2):30-4. PubMed ID: 11880146
[TBL] [Abstract][Full Text] [Related]
15. Anergy induction in encephalitogenic T cells by brain microvessel endothelial cells is inhibited by interleukin-1.
Bourdoulous S; Béraud E; Le Page C; Zamora A; Ferry A; Bernard D; Strosberg AD; Couraud PO
Eur J Immunol; 1995 May; 25(5):1176-83. PubMed ID: 7539749
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcal enterotoxin enhances the activation of rat encephalitogenic T cells by myelin basic protein.
Sun D
J Neuroimmunol; 1993 Jul; 46(1-2):5-10. PubMed ID: 7689594
[TBL] [Abstract][Full Text] [Related]
17. Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects.
Happ MP; Wettstein P; Dietzschold B; Heber-Katz E
J Immunol; 1988 Sep; 141(5):1489-94. PubMed ID: 2457618
[TBL] [Abstract][Full Text] [Related]
18. Resistance to tolerance induction in the diabetes-prone biobreeding rat as one manifestation of abnormal responses to superantigens.
Sellins KS; Gold DP; Bellgrau D
Diabetologia; 1996 Jan; 39(1):28-36. PubMed ID: 8720600
[TBL] [Abstract][Full Text] [Related]
19. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes.
Lider O; Santos LM; Lee CS; Higgins PJ; Weiner HL
J Immunol; 1989 Feb; 142(3):748-52. PubMed ID: 2464023
[TBL] [Abstract][Full Text] [Related]
20. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells.
Saoudi A; Simmonds S; Huitinga I; Mason D
J Exp Med; 1995 Aug; 182(2):335-44. PubMed ID: 7543135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
